 |
市场调查报告书
商品编码
1705653
全球医药市场人工智慧（AI）的部署模式、产品、技术、药物类型、应用、最终用户和地区Global Artificial Intelligence (AI) In Pharmaceutical Market, By Deployment Mode, By Offering, By Technology, By Drug Type, By Application, By End User, By Geography |
||||||
价格
简介目录
2025 年全球人工智慧 (AI) 医药市场规模估计为 14.661 亿美元，预计到 2032 年将达到 104.069 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 32.3%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 14.661亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 32.30% | 2032年价值预测 | 104.069亿美元 |
数字。 2025年全球市场占有率（%）
人工智慧 (AI) 已成为一项变革性技术，它将彻底改变製药业。透过利用大量数据和复杂演算法，人工智慧有可能帮助製药公司加速药物研发、简化临床试验并实现更准确的诊断和治疗。人工智慧透过快速分析大量资料集并识别可能带来新治疗方法的关係，增强了製药科学家的工作能力。人工智慧使研究人员能够以前所未有的规模和速度分析基因序列资讯和电子健康记录。该技术可以帮助发现新的治疗方法并预测重新利用现有药物治疗其他疾病的潜力。人工智慧可望增强人类的能力，提高药物研发的效率，并更快为患者带来创新的新药。
市场动态：
全球人工智慧 (AI) 在医药市场的成长受到控製药物发现和开发成本、缩短药物开发週期和精准医疗进步的日益增长的需求的推动。人工智慧可以加速药物研发，减少代价高昂的后期临床试验失败，并帮助药物更快推向市场。然而，人工智慧模型缺乏可解释性以及对其融入决策的怀疑可能会阻碍其采用。增加药品资料集的可用性和加强法律规范可能会提供巨大的成长机会。如果做得正确，可以克服可解释性问题和缺乏专业知识，从而充分发挥这项创新技术的潜力。
本研究的主要特点
- 本报告对全球製药人工智慧 (AI) 市场进行了详细分析，并以 2024 年为基准年，展示了预测期 (2025-2032) 的市场规模和年复合成长率（CAGR%）。
- 它揭示了各个领域的潜在商机，并解释了该市场的引人注目的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
- 全球製药人工智慧 (AI) 市场的主要企业已根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行了分析。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球製药业人工智慧 (AI) 市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球製药业人工智慧 (AI) 市场中使用的各种策略矩阵来简化决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管情景
- 收购与合作场景
- 资金筹措与投资
- PEST分析
- 波特分析
第四章。全球製药市场人工智慧（AI）-冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 2021 年至 2032 年全球製药业人工智慧 (AI) 市场（依部署模式）
- 云
- 本地
6. 2021 年至 2032 年全球製药业人工智慧 (AI) 市场
- 硬体
- 软体
- 服务
7. 2021 年至 2032 年全球製药业人工智慧 (AI) 市场（按技术划分）
- 自然语言处理
- 情境感知处理
- 深度学习
- 查询方法
- 其他的
8. 2021 年至 2032 年全球製药业人工智慧 (AI) 市场（按药物类型）
- 大分子
- 小分子
第九章。 2021 年至 2032 年全球製药业人工智慧 (AI) 市场应用状况
- 药物研发
- 临床试验
- 研究与开发
- 医药製造与供应链
- 其他的
第 10 章。 2021 年至 2032 年，全球製药业人工智慧 (AI) 市场（按最终用户划分）
- 製药和生物技术公司
- 医院和诊断中心
- 学术研究所
- 其他的
第 11 章。 2021 年至 2032 年按地区分類的全球製药人工智慧 (AI) 市场
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十二章竞争格局
- 公司简介
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
第 13 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十四章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI7209
Global Artificial Intelligence (AI) In Pharmaceutical Market is estimated to be valued at USD 1,466.1 Mn in 2025 and is expected to reach USD 10,406.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 32.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1,466.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 32.30% | 2032 Value Projection: | USD 10,406.9 Mn |
Figure. Global Artificial Intelligence (AI) In Pharmaceutical Market Share (%), By Region 2025
Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery, streamline clinical trials and enable more precise diagnosis and treatment. AI augments the work of pharmaceutical scientists by swiftly analyzing huge datasets to identify relationships that may lead to new therapies. With AI, researchers can analyze genetic sequencing information or electronic health records at an unprecedented scale and speed. The technology helps discover new therapies and predict which existing drugs could be repurposed to treat other conditions. AI promises to augment human capabilities, make pharmaceutical R&D more efficient and bring innovative new medicines to patients faster.
Market Dynamics:
Global artificial intelligence (AI) in pharmaceutical market growth is driven by rising need to control drug discovery and development costs, reduce the drug development cycle time and advance precision medicine. AI can accelerate drug discovery, reduce expensive late-stage clinical trial failures and help launch drugs faster. However, lack of interpretability of AI models and skepticism about integrating it into decision-making can hamper its adoption. Growing availability of pharma data sets and encouraging regulatory frameworks can offer significant growth opportunities. If addressed properly, interpretability issues and lack of expertise can be overcome to extract full potential from this transformative technology.
Key Features of the Study:
- This report provides in-depth analysis of the global artificial intelligence (AI) in pharmaceutical market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial intelligence (AI) in pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IBM, Microsoft, AWS, Google, Anthropic, Berg Health and InSilico Medicine
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global artificial intelligence (AI) in pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) in pharmaceutical market
Detailed Segmentation-
- By Deployment Mode
- Cloud
- On-Premise
- By Offering
- Hardware
- Software
- Services
- By Technology
- Natural Language Processing
- Context-Aware Processing
- Deep Learning
- Querying Method
- Other
- By Drug Type
- Large Molecules
- Small Molecules
- By Application
- Drug Discovery
- Clinical Trial
- Research & Development
- Drug Manufacturing and Supply Chain
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostic Centers
- Academic & Research Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Deployment Mode
- Market Snapshot, By Offering
- Market Snapshot, By Technology
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Artificial Intelligence (AI) in Pharmaceutical Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Deployment Mode, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cloud
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- On-Premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Offering, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hardware
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Software
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Services
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Technology, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Natural Language Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Context-Aware Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Deep Learning
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Querying Method
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Drug Type, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Application, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical Trial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Drug Manufacturing and Supply Chain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Artificial Intelligence (AI) in Pharmaceutical Market, By End User, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals and Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Region, 2021 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Company Profiles
- NVIDIA Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
- NVIDIA Corporation
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
